Replies to post #11563 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Dr. Cox earned $90K in cash from NABI during 2007. The rest of Cox’s compensation figure shown in NABI’s DEF14a filing comes from 40K options Cox received in May 2007, which are exercisable at $5.20 and are currently under water:

http://www.sec.gov/Archives/edgar/data/72444/000137318507000020/xslF345X02/edgar.xml

Why does any of this matter to GTC investors?